Considering we are still making revenue and new lines may soon add to the product mix, does this now represent an undervalued stock? I'm asking myself how much will earnings fall and if DPS holds at say (guessing now) 3.5 is that good value and what are the risks?
- Forums
- ASX - By Stock
- ACR
- Ann: Acrux announces court ruling on Axiron patent families-ACR.AX
Ann: Acrux announces court ruling on Axiron patent families-ACR.AX, page-40
Featured News
Add ACR (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.4¢ |
Change
-0.001(2.22%) |
Mkt cap ! $12.79M |
Open | High | Low | Value | Volume |
4.5¢ | 4.5¢ | 4.4¢ | $10.91K | 243.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 82022 | 4.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.6¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 82022 | 0.044 |
2 | 547000 | 0.043 |
2 | 94414 | 0.041 |
5 | 442500 | 0.040 |
1 | 78000 | 0.038 |
Price($) | Vol. | No. |
---|---|---|
0.046 | 10000 | 1 |
0.048 | 44500 | 3 |
0.049 | 120000 | 1 |
0.052 | 103000 | 2 |
0.055 | 120542 | 1 |
Last trade - 15.11pm 15/11/2024 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online